GMED – Globus Medical, Inc.
Float Short %
4.28
Margin Of Safety %
Put/Call OI Ratio
0.15
EPS Next Q Diff
0.03
EPS Last/This Y
2.46
EPS This/Next Y
0.4
Price
62.56
Target Price
83
Analyst Recom
1.8
Performance Q
6.69
Relative Volume
0.5
Beta
1.15
Ticker: GMED
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-25 | GMED | 54.48 | 0.16 | 0.00 | 8267 |
| 2025-07-28 | GMED | 54.29 | 0.16 | 0.30 | 8340 |
| 2025-07-29 | GMED | 54 | 0.16 | 0.59 | 8356 |
| 2025-07-30 | GMED | 53.47 | 0.16 | 0.25 | 8357 |
| 2025-07-31 | GMED | 52.62 | 0.16 | 0.31 | 8352 |
| 2025-08-01 | GMED | 52.63 | 0.16 | 0.05 | 8374 |
| 2025-08-04 | GMED | 53.65 | 0.16 | 1.00 | 8447 |
| 2025-08-05 | GMED | 53.6 | 0.16 | 0.19 | 8473 |
| 2025-08-06 | GMED | 52.83 | 0.16 | 10.09 | 8624 |
| 2025-08-07 | GMED | 54.09 | 0.24 | 0.29 | 9323 |
| 2025-08-08 | GMED | 58.68 | 0.26 | 1.21 | 12555 |
| 2025-08-11 | GMED | 59.49 | 0.26 | 0.08 | 12772 |
| 2025-08-12 | GMED | 61.87 | 0.26 | 0.02 | 12760 |
| 2025-08-13 | GMED | 62.8 | 0.15 | 0.01 | 19610 |
| 2025-08-14 | GMED | 59.97 | 0.15 | 0.05 | 19886 |
| 2025-08-15 | GMED | 60.59 | 0.21 | 0.57 | 15426 |
| 2025-08-18 | GMED | 60.24 | 0.15 | 0.13 | 10366 |
| 2025-08-19 | GMED | 61.21 | 0.15 | 0.11 | 10251 |
| 2025-08-20 | GMED | 60.74 | 0.15 | 0.03 | 10392 |
| 2025-08-21 | GMED | 60.5 | 0.15 | 0.08 | 10355 |
| 2025-08-22 | GMED | 62.52 | 0.15 | 0.05 | 10396 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-25 | GMED | 54.48 | 0.5 | - | 3.16 |
| 2025-07-28 | GMED | 54.17 | 0.5 | - | 3.16 |
| 2025-07-29 | GMED | 54.04 | 0.5 | - | 3.16 |
| 2025-07-30 | GMED | 53.45 | 0.5 | - | 3.16 |
| 2025-07-31 | GMED | 52.63 | 0.5 | - | 3.16 |
| 2025-08-01 | GMED | 52.64 | 0.5 | - | 3.16 |
| 2025-08-04 | GMED | 53.63 | 0.5 | - | 3.16 |
| 2025-08-05 | GMED | 53.64 | 0.5 | - | 3.16 |
| 2025-08-06 | GMED | 52.85 | 0.5 | - | 3.16 |
| 2025-08-07 | GMED | 54.07 | 0.5 | - | 3.16 |
| 2025-08-08 | GMED | 58.65 | 0.5 | - | 3.16 |
| 2025-08-11 | GMED | 59.44 | 0.5 | - | 3.16 |
| 2025-08-12 | GMED | 61.88 | -5.2 | - | 3.22 |
| 2025-08-13 | GMED | 62.79 | -5.2 | - | 3.22 |
| 2025-08-14 | GMED | 59.99 | -5.2 | - | 3.22 |
| 2025-08-15 | GMED | 60.56 | -5.2 | - | 3.22 |
| 2025-08-18 | GMED | 60.26 | -7.5 | - | 3.22 |
| 2025-08-19 | GMED | 61.17 | -7.5 | - | 3.22 |
| 2025-08-20 | GMED | 60.70 | -7.5 | - | 3.22 |
| 2025-08-21 | GMED | 60.50 | -7.5 | - | 3.22 |
| 2025-08-22 | GMED | 62.56 | -7.5 | - | 3.22 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-25 | GMED | -0.03 | 1.68 | 4.03 |
| 2025-07-28 | GMED | -0.03 | 0.64 | 4.03 |
| 2025-07-29 | GMED | -0.03 | 0.64 | 4.03 |
| 2025-07-30 | GMED | -0.03 | 0.64 | 4.03 |
| 2025-07-31 | GMED | -0.03 | 0.64 | 4.03 |
| 2025-08-01 | GMED | -0.03 | 0.64 | 4.03 |
| 2025-08-04 | GMED | -0.03 | -0.12 | 4.03 |
| 2025-08-05 | GMED | -0.03 | -0.12 | 4.03 |
| 2025-08-06 | GMED | -0.03 | -0.12 | 4.03 |
| 2025-08-07 | GMED | -0.03 | -0.12 | 4.03 |
| 2025-08-08 | GMED | -0.03 | -0.12 | 4.03 |
| 2025-08-11 | GMED | -0.03 | -0.43 | 4.03 |
| 2025-08-12 | GMED | -0.03 | -0.43 | 4.27 |
| 2025-08-13 | GMED | -0.03 | -0.43 | 4.27 |
| 2025-08-14 | GMED | -0.03 | -0.43 | 4.28 |
| 2025-08-15 | GMED | -0.03 | -0.43 | 4.28 |
| 2025-08-18 | GMED | -0.03 | 1.37 | 4.28 |
| 2025-08-19 | GMED | -0.03 | 1.37 | 4.28 |
| 2025-08-20 | GMED | -0.03 | 1.37 | 4.28 |
| 2025-08-21 | GMED | -0.03 | 1.37 | 4.28 |
| 2025-08-22 | GMED | -0.03 | 1.37 | 4.28 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.86
Avg. EPS Est. Current Quarter
0.77
Avg. EPS Est. Next Quarter
0.89
Insider Transactions
-0.03
Institutional Transactions
1.37
Beta
1.15
Average Sales Estimate Current Quarter
734
Average Sales Estimate Next Quarter
778
Fair Value
62.42
Quality Score
71
Growth Score
99
Sentiment Score
65
Actual DrawDown %
34.1
Max Drawdown 5-Year %
-47.9
Target Price
83
P/E
24.13
Forward P/E
17.07
PEG
2.53
P/S
3.21
P/B
1.97
P/Free Cash Flow
16.01
EPS
2.59
Average EPS Est. Cur. Y
3.22
EPS Next Y. (Est.)
3.61
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
13.58
Relative Volume
0.5
Return on Equity vs Sector %
-16.4
Return on Equity vs Industry %
-10.4
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.05
EBIT Estimation
Globus Medical, Inc.Sector: Healthcare
Industry: Medical Devices
Employees: 5300
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip and knee joint solutions, including modular hip stems and acetabular cups for total hip arthroplasty, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants; and neuromonitoring services, which provides onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also offers enabling technologies, such as imaging, navigation, and robotics (INR) solutions for assisted surgery, which includes the ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures with screw and interbody spacer placement applications; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative, image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
stock quote shares GMED – Globus Medical, Inc. Stock Price stock today
news today GMED – Globus Medical, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch GMED – Globus Medical, Inc. yahoo finance google finance
stock history GMED – Globus Medical, Inc. invest stock market
stock prices GMED premarket after hours
ticker GMED fair value insiders trading